National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Immune Checkpoint Inhibitors Market Research Report 2017

Global Immune Checkpoint Inhibitors Market Research Report 2017

Goods_sn:Zhongyouxin-gz2

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Immune Checkpoint Inhibitors Market Research Report 2017

Hard Copy: 2900 USD 
PDF Copy (single user): 2900 USD
Enterprise wide License: 5800 USD
Pages: 126
Tables and Figures: 124
Published Date: May. 2017
Publisher: QYR Pharm & Healthcare Research Center
Contact: Tel: 001-6262952442 0086-1082945717; Email: sales@qyresearch.com

Summary

This report studies the Immune Checkpoint Inhibitors market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Immune Checkpoint Inhibitors market by product type and applications/end industries.

The global Immune Checkpoint Inhibitors market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immune Checkpoint Inhibitors.

Europe also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.

The major players in global Immune Checkpoint Inhibitors market include Bristol Myer Squibb, AstraZeneca, Merck & Co., Roche / Genentech, Incyte Corporation, NewLink Genetics, ArGEN-X, Seattle Genetics, Pfizer, MacroGenics, Celldex Therapeutics, CureTech, Immutep, Innate Pharma, Sorrento Therapeutics, GlaxoSmithKline, GITR, Inc..

Geographically, this report is segmented into several key Regions, with Sales, Sales, revenue, Market Share (%) and Growth Rate (%) of Immune Checkpoint Inhibitors in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa


On the basis of product, the Immune Checkpoint Inhibitors market is primarily split into 
PD-1/PD-L1

CTLA-4 



On the basis on the end users/applications, this report covers 
Lung Cancer
Colorectal Cancer
Breast Cancer 
Prostate Cancer
Melanoma
Blood Cancers

Table of Contents
Global Immune Checkpoint Inhibitors Market Research Report 2017
1 Immune Checkpoint Inhibitors Market Overview
1.1 Immune Checkpoint Inhibitors Product Overview
1.2 Immune Checkpoint Inhibitors Segment by Types (Product Category)
1.2.1 Global Immune Checkpoint Inhibitors Sales and Growth (%) Comparison by Types (2012-2022)
1.2.2 Global Immune Checkpoint Inhibitors Sales Market Share (%) by Types in 2016
1.2.3 PD-1/PD-L1
1.2.4 CTLA-4
1.3 Global Immune Checkpoint Inhibitors Segment by Applications
1.3.1 Global Immune Checkpoint Inhibitors Sales (K Pcs) Comparison by Applications (2012-2022)
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 Breast Cancer
1.3.5 Prostate Cancer
1.3.6 Melanoma
1.3.7 Blood Cancers
1.4 Global Immune Checkpoint Inhibitors Market by Regions (2012-2022)
1.4.1 Global Immune Checkpoint Inhibitors Market Size and Growth (%) Comparison by Regions (2012-2022)
1.4.2 North America Immune Checkpoint Inhibitors Status and Prospect (2012-2022)
1.4.3 Asia-Pacific Immune Checkpoint Inhibitors Status and Prospect (2012-2022)
1.4.4 Europe Immune Checkpoint Inhibitors Status and Prospect (2012-2022)
1.4.5 South America Immune Checkpoint Inhibitors Status and Prospect (2012-2022)
1.4.6 Middle East and Africa Immune Checkpoint Inhibitors Status and Prospect (2012-2022)
1.5 Global Immune Checkpoint Inhibitors Market Size (2012-2022)
1.5.1 Global Immune Checkpoint Inhibitors Revenue (Million USD) Status and Outlook (2012-2022)
1.5.2 Global Immune Checkpoint Inhibitors Sales (K Pcs) Status and Outlook (2012-2022)
2 Global Immune Checkpoint Inhibitors Market Competition by Manufacturers/Brand
2.1 Global Immune Checkpoint Inhibitors Sales (K Pcs) and Share by Manufacturers (2012-2017)
2.2 Global Immune Checkpoint Inhibitors Revenue (Million USD) and Share by Manufacturers (2012-2017)
2.3 Global Immune Checkpoint Inhibitors Average Price (USD/Pcs) by Manufacturers (2012-2017)
2.4 Manufacturers Immune Checkpoint Inhibitors Manufacturing Base Distribution, Sales Area, Product Types
2.5 Immune Checkpoint Inhibitors Market Competitive Situation and Trends
2.5.1 Immune Checkpoint Inhibitors Market Concentration Rate
2.5.2 Immune Checkpoint Inhibitors Market Share (%) of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD) by Regions (2012-2017)
3.2 Global Immune Checkpoint Inhibitors Sales (K Pcs) and Market Share (%) by Regions (2012-2017)
3.3 Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share (%) by Regions (2012-2017)
3.3 Global Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.5 North America Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.6 Europe Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.7 Asia-Pacific Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
3.8 South America Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
3.9 Middle East and Africa Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
4 Global Immune Checkpoint Inhibitors Sales, Revenue, Price Trend by Types
4.1 Global Immune Checkpoint Inhibitors Sales (K Pcs) and Market Share (%) by Types (2012-2017)
4.2 Global Immune Checkpoint Inhibitors Revenue and Market Share (%) by Types (2012-2017)
4.3 Global Immune Checkpoint Inhibitors Price (USD/Pcs) by Type (2012-2017)
4.4 Global Immune Checkpoint Inhibitors Sales Growth by Type (2012-2017)
5 Global Immune Checkpoint Inhibitors Market Analysis by Applications
5.1 Global Immune Checkpoint Inhibitors Sales (K Pcs) and Market Share (%) by Applications (2012-2017)
5.2 Global Immune Checkpoint Inhibitors Sales Growth Rate (%) by Applications (2012-2017)
6 Global Immune Checkpoint Inhibitors Manufacturers Profiles/Analysis
6.1 Bristol Myer Squibb
6.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.1.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.2.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck & Co.
6.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.3.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck & Co. Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche / Genentech
6.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.4.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.4.2.1 Product A
6.4.2.2 Product A
6.4.3 Roche / Genentech Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Incyte Corporation
6.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.5.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Incyte Corporation Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 NewLink Genetics
6.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.6.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 NewLink Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 ArGEN-X
6.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.7.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 ArGEN-X Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Seattle Genetics
6.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.8.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Seattle Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Pfizer
6.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.9.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pfizer Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.9.4 Main Business/Business Overview
6.10 MacroGenics
6.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
6.10.2 Immune Checkpoint Inhibitors Product Category, End Uses and Specification
6.10.2.1 Type A
6.10.2.2 Type B
6.10.3 MacroGenics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Celldex Therapeutics
6.12 CureTech
6.13 Immutep
6.14 Innate Pharma
6.15 Sorrento Therapeutics
6.16 GlaxoSmithKline
6.25 Company 25
6.26 Company 26
6.27 Company 27
6.28 Company 28
6.29 Company 29
6.30 Company 30
7 Immune Checkpoint Inhibitors Manufacturing Cost Analysis
7.1 Immune Checkpoint Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Immune Checkpoint Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immune Checkpoint Inhibitors Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Immune Checkpoint Inhibitors Market Forecast (2017-2022)
11.1 Global Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.1.1 Global Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
11.1.2 Global Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
11.1.3 Global Immune Checkpoint Inhibitors Price and Trend Forecast (2017-2022)
11.2 Global Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Forecast by Regions (2017-2022)
11.2.1 North America Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.2 Europe Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.3 Asia-Pacific Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.4 South America Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.2.5 Middle East and Africa Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Forecast (2017-2022)
11.3 Global Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) Forecast by Type (2017-2022)
11.4 Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures 
Figure Global Market Size (Million USD) Status and Outlook 2012-2022
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Market Split by Regions
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Figure Product Picture of Immune Checkpoint Inhibitors
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) by Types in 2016
Figure Product Picture of PD-1/PD-L1
Table Major Manufacturers of PD-1/PD-L1
Figure Product Picture of CTLA-4
Table Major Manufacturers of CTLA-4
Figure Product Picture of 
Table Major Manufacturers of 
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Comparison by Applications (2012-2022)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) by Applications in 2016
Figure Lung Cancer Examples
Figure Colorectal Cancer Examples
Figure Breast Cancer Examples
Figure Prostate Cancer Examples
Figure Melanoma Examples
Figure Global Immune Checkpoint Inhibitors Market Size Comparison and Growth (%) by Regions (2012-2022)
Table Global Market Immune Checkpoint Inhibitors Revenue (Million USD) Comparison by Regions 2012-2022
Figure North America Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Immune Checkpoint Inhibitors Sales (K Pcs) Status and Outlook (2012-2022)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) of Key Manufacturers (2012-2017)
Table Global Immune Checkpoint Inhibitors Sales Share (%) by Manufacturers (2012-2017)
Figure 2016 Immune Checkpoint Inhibitors Sales Share (%) by Manufacturers
Figure 2017Immune Checkpoint Inhibitors Sales Share (%) by Manufacturers
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Immune Checkpoint Inhibitors Revenue Share (%) by Manufacturers (2012-2017)
Table 2016 Global Immune Checkpoint Inhibitors Revenue Share (%) by Manufacturers
Table 2016 Global Immune Checkpoint Inhibitors Revenue Share (%) by Manufacturers
Table Global Market Immune Checkpoint Inhibitors Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Immune Checkpoint Inhibitors Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Immune Checkpoint Inhibitors Manufacturing Base Distribution and Sales Area
Table Manufacturers Immune Checkpoint Inhibitors Product Category
Figure Immune Checkpoint Inhibitors Market Share (%) of Top 3 Manufacturers
Figure Immune Checkpoint Inhibitors Market Share (%) of Top 5 Manufacturers
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) by Regions (2012-2017)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) by Regions (2012-2017)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global Immune Checkpoint Inhibitors Sales Market Share (%) by Regions
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) by Regions (2012-2017)
Table Global Immune Checkpoint Inhibitors Revenue Market Share (%) by Regions (2012-2017)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Immune Checkpoint Inhibitors Revenue Market Share (%) by Regions
Table Global Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table North America Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Europe Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Asia-Pacific Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table South America Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Middle East and Africa Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%) (2012-2017)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) by Types (2012-2017)
Table Global Immune Checkpoint Inhibitors Sales Share (%) by Types (2012-2017)
Figure Sales Market Share (%) of Immune Checkpoint Inhibitors by Types (2012-2017)
Figure 2016 Sales Market Share (%) of Immune Checkpoint Inhibitors by Types
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) by Types (2012-2017)
Table Global Immune Checkpoint Inhibitors Revenue Share (%) by Types (2012-2017)
Figure Revenue Share (%) of Immune Checkpoint Inhibitors by Types (2012-2017)
Figure 2016 Revenue Market Share (%) of Immune Checkpoint Inhibitors by Types
Table Global Immune Checkpoint Inhibitors Price (USD/Pcs) by Types (2012-2017)
Figure Global Immune Checkpoint Inhibitors Sales Growth (%) by Type (2012-2017)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) by Applications (2012-2017)
Table Global Immune Checkpoint Inhibitors Sales Market Share (%) by Applications (2012-2017)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) by Applications (2012-2017)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) by Applications in 2016
Table Global Immune Checkpoint Inhibitors Sales Growth Rate (%) by Applications (2012-2017)
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate (%) by Applications (2012-2017)
Table Bristol Myer Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol Myer Squibb Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure AstraZeneca Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure AstraZeneca Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure AstraZeneca Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Merck & Co. Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure Merck & Co. Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure Merck & Co. Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table Roche / Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche / Genentech Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Roche / Genentech Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure Roche / Genentech Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure Roche / Genentech Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table Incyte Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Incyte Corporation Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Incyte Corporation Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure Incyte Corporation Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure Incyte Corporation Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table NewLink Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table NewLink Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure NewLink Genetics Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure NewLink Genetics Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure NewLink Genetics Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table ArGEN-X Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ArGEN-X Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure ArGEN-X Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure ArGEN-X Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure ArGEN-X Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Seattle Genetics Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure Seattle Genetics Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure Seattle Genetics Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure Pfizer Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure Pfizer Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure Pfizer Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table MacroGenics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MacroGenics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs), Gross Margin (%) and Market Share (%) (2012-2017)
Figure MacroGenics Immune Checkpoint Inhibitors Sales Growth Rate (%) (2012-2017)
Figure MacroGenics Immune Checkpoint Inhibitors Sales Market Share (%) (2012-2017)
Figure MacroGenics Immune Checkpoint Inhibitors Revenue Market Share (%) (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Checkpoint Inhibitors
Figure Immune Checkpoint Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Immune Checkpoint Inhibitors Major Manufacturers in 2016
Table Major Buyers of Immune Checkpoint Inhibitors
Table Distributors/Traders List
Figure Global Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure Global Immune Checkpoint Inhibitors Price and Trend Forecast (2017-2022)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Regions (2017-2022)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure North America Immune Checkpoint Inhibitors Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Immune Checkpoint Inhibitors Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Immune Checkpoint Inhibitors Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure South America Immune Checkpoint Inhibitors Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Immune Checkpoint Inhibitors Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Immune Checkpoint Inhibitors Sales (Million USD) Forecast by Type (2017-2022)
Figure Global Immune Checkpoint Inhibitors Sales Market Share (%) Forecast by Type (2017-2022)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global Immune Checkpoint Inhibitors Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Immune Checkpoint Inhibitors Sales Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources




Request sample If you need any reports sample, just let us know.